![Thomas Bures](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 200 962 $ al 31/07/2026
Thomas Bures is Chief Accounting Officer at Bruker Corp.
since 2025.
Formerly, Mr. Bures was Senior VP, Chief Financial & Accounting Officer at Pieris Pharmaceuticals, Inc. from 2021 to 2024, Vice President & Controller at Genocea Biosciences, Inc. from 2015 to 2017, Vice President & Assistant Controller at PAREXEL International Corp., and Chief Financial Officer at Palvella Therapeutics, Inc. Education includes an undergraduate degree from College of the Holy Cross (Massachusetts).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/02/2026 | 3.198 ( 0 % ) | 200 962 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BRUKER CORPORATION | Comptroller/Controller/Auditor | 13/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| PIERIS PHARMACEUTICALS | Director Financiero/CFO | 13/12/2024 |
| GENOCEA BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 01/12/2017 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
